+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Motif Bio Presents New Iclaprim Data At Eccmid 2019 is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Press Release Motif Bio Presents New Iclaprim Data At Eccmid 2019 | RobinsPost News & Noticias

Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024


SAN DIEGO--(BUSINESS WIRE)--Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation ... This press release may contain ... Read More

Forbes Press Releases


In this section, you’ll find the latest Forbes press releases and news announcements. The collective net worth of Korea’s 50 Richest on the 2024 Forbes list rose slightly to US$115 billion ... Read More

INmune Bio Inc. Presents Data on INB03’s Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024


Novel Immunotherapy Approach Targets Soluble Tumor Necrosis Factor to Overcome Resistance and Enhance Therapeutic Outcome in High-Risk Breast Cancer Sign up for our newsletter to get the latest on ... Read More

IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103


NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its ... Read More

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting


“Our team is looking forward to share new data from our strong portfolio ... Forward-looking statements in this press release include, but are not limited to, statements that relate to the anticipated ... Read More

Press Releases and Statements


April 10, 2024 • Narratively and VPM partner on five-part, music-infused series about a group of men's efforts to break free from addiction and incarceration. NPR Music's Tiny Desk x globalFEST ... Read More

Seattle Seahawks Press Releases


Seattle Seahawks and Virginia Mason Franciscan Health Team with the Nick of Time Foundation to Prevent Sudden Cardiac Arrest in Local Youth Seahawks & Virginia Mason Franciscan Health to Host Free ... Read More

Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at the AACR Annual Meeting


today presented new preclinical data on its KRASG12C inhibitor, FMC-376, at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, California. The new findings ... Read More

Thursday Releases First New Song in 13 Years, Plans to Continue Recording Together


It’s been 13 years since post-hardcore band Thursday released its most recent album, “No Devolución,” but the group has finally dropped a new song. The track, titled “Application for ... Read More

INmune Bio Inc. Presents Data on INB03’s Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024


The poster, titled, “INB03: a new immune checkpoint inhibitor that ... Any statements contained in this press release that do not describe historical facts may constitute forward-looking ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus